{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:35:47Z","timestamp":1783949747973,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T00:00:00Z","timestamp":1336953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1038\/aps.2012.34","type":"journal-article","created":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T09:01:36Z","timestamp":1336986096000},"page":"823-831","source":"Crossref","is-referenced-by-count":116,"title":["Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells"],"prefix":"10.1038","volume":"33","author":[{"given":"Wanisa","family":"Punfa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supachai","family":"Yodkeeree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pornsiri","family":"Pitchakarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadarat","family":"Ampasavate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pornngarm","family":"Limtrakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,14]]},"reference":[{"key":"BFaps201234_CR1","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","volume":"53","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM . Mechanisms of cancer drug resistance. Annu Rev Med 2002; 53: 615\u201327.","journal-title":"Annu Rev Med"},{"key":"BFaps201234_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrd1984","volume":"5","author":"G Szakacs","year":"2006","unstructured":"Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM . Targeting multidrug resistance in cancer. Nat Rev Drug Discov 2006; 5: 219\u201334.","journal-title":"Nat Rev Drug Discov"},{"key":"BFaps201234_CR3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/ijc.21063","volume":"117","author":"T Fujita","year":"2005","unstructured":"Fujita T, Washio K, Takabatake D, Takahashi H, Yoshitomi S, Tsukuda K, et al. Proteasome inhibitors can alter the signaling pathways and attenuate the P-glycoprotein-mediated multidrug resistance. Int J Cancer 2005; 117: 670\u201382.","journal-title":"Int J Cancer"},{"key":"BFaps201234_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00280-004-0848-4","volume":"54","author":"P Limtrakul","year":"2004","unstructured":"Limtrakul P, Khantamat O, Pintha K . Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract. Cancer Chemother Pharmacol 2004; 54: 525\u201330.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFaps201234_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jnutbio.2010.11.005","volume":"23","author":"P Pitchakarn","year":"2012","unstructured":"Pitchakarn P, Ohnuma S, Pintha K, Pompimon W, Ambudkar SV, Limtrakul P . Kuguacin J isolated from Momordica charantia leaves inhibits P-glycoprotein (ABCB1)-mediated multidrug resistance. J Nutr Biochem 2012; 23: 76\u201384.","journal-title":"J Nutr Biochem"},{"key":"BFaps201234_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.phymed.2010.07.014","volume":"18","author":"W Chanmahasathien","year":"2011","unstructured":"Chanmahasathien W, Ampasavate C, Greger H, Limtrakul P . Stemona alkaloids, from traditional Thai medicine, increase chemosensitivity via P-glycoprotein-mediated multidrug resistance. Phytomedicine 2011; 18: 199\u2013204.","journal-title":"Phytomedicine"},{"key":"BFaps201234_CR7","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/S0024-3205(98)00216-1","volume":"62","author":"N Romiti","year":"1998","unstructured":"Romiti N, Tongiani R, Cervelli F, Chieli E . Effects of curcumin on P-glycoprotein in primary cultures of rat hepatocytes. Life Sci 1998; 62: 2349\u201358.","journal-title":"Life Sci"},{"key":"BFaps201234_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0006-2952(02)01224-8","volume":"64","author":"S Anuchapreeda","year":"2002","unstructured":"Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, Limtrakul PN . Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol 2002; 64: 573\u201382.","journal-title":"Biochem Pharmacol"},{"key":"BFaps201234_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2174\/187152006776930918","volume":"6","author":"S Singh","year":"2006","unstructured":"Singh S, Khar A . Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med Chem 2006; 6: 259\u201370.","journal-title":"Anticancer Agents Med Chem"},{"key":"BFaps201234_CR10","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.bcp.2004.07.009","volume":"68","author":"W Chearwae","year":"2004","unstructured":"Chearwae W, Anuchapreeda S, Nandigama K, Ambudkar SV, Limtrakul P . Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder. Biochem Pharmacol 2004; 68: 2043\u201352.","journal-title":"Biochem Pharmacol"},{"key":"BFaps201234_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.canlet.2008.03.009","volume":"269","author":"AB Kunnumakkara","year":"2008","unstructured":"Kunnumakkara AB, Anand P, Aggarwal BB . Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 2008; 269: 199\u2013225.","journal-title":"Cancer Lett"},{"key":"BFaps201234_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jcis.2010.05.022","volume":"351","author":"MM Yallapu","year":"2010","unstructured":"Yallapu MM, Gupta BK, Jaggi M, Chauhan SC . Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface Sci 2010; 351: 19\u201329.","journal-title":"J Colloid Interface Sci"},{"key":"BFaps201234_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejps.2009.07.006","volume":"38","author":"A Cirstoiu-Hapca","year":"2009","unstructured":"Cirstoiu-Hapca A, Buchegger F, Bossy L, Kosinski M, Gurny R, Delie F . Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells. Eur J Pharm Sci 2009; 38: 230\u20137.","journal-title":"Eur J Pharm Sci"},{"key":"BFaps201234_CR14","doi-asserted-by":"publisher","first-page":"10643","DOI":"10.1021\/ja801631c","volume":"130","author":"Y Cheng","year":"2008","unstructured":"Cheng Y, C Samia A, Meyers JD, Panagopoulos I, Fei B, Burda C . Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J Am Chem Soc 2008; 130: 10643\u20137.","journal-title":"J Am Chem Soc"},{"key":"BFaps201234_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1517\/14728222.8.4.335","volume":"8","author":"CO Noble","year":"2004","unstructured":"Noble CO, Kirpotin DB, Hayes ME, Mamot C, Hong K, Park JW, et al. Development of ligand-targeted liposomes for cancer therapy. Expert Opin Ther Targets 2004; 8: 335\u201353.","journal-title":"Expert Opin Ther Targets"},{"key":"BFaps201234_CR16","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.nano.2010.11.004","volume":"7","author":"T Lei","year":"2011","unstructured":"Lei T, Srinivasan S, Tang Y, Manchanda R, Nagesetti A, Fernandez-Fernandez A, et al. Comparing cellular uptake and cytotoxicity of targeted drug carriers in cancer cell lines with different drug resistance mechanisms. Nanomedicine 2011; 7: 324\u201332.","journal-title":"Nanomedicine"},{"key":"BFaps201234_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/10611860400010697","volume":"12","author":"H Wartlick","year":"2004","unstructured":"Wartlick H, Michaelis K, Balthasar S, Strebhardt K, Kreuter J, Langer K . Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells. J Drug Target 2004; 12: 461\u201371.","journal-title":"J Drug Target"},{"key":"BFaps201234_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2007.03.012","volume":"120","author":"P Kocbek","year":"2007","unstructured":"Kocbek P, Obermajer N, Cegnar M, Kos J, Kristl J . Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Control Release 2007; 120: 18\u201326.","journal-title":"J Control Release"},{"key":"BFaps201234_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejpb.2009.09.014","volume":"74","author":"N Debotton","year":"2010","unstructured":"Debotton N, Zer H, Parnes M, Harush-Frenkel O, Kadouche J, Benita S . A quantitative evaluation of the molecular binding affinity between a monoclonal antibody conjugated to a nanoparticle and an antigen by surface plasmon resonance. Eur J Pharm Biopharm 2010; 74: 148\u201356.","journal-title":"Eur J Pharm Biopharm"},{"key":"BFaps201234_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1309\/AC1M-4TY4-U0TN-EN7T","volume":"113","author":"IO Ng","year":"2000","unstructured":"Ng IO, Liu CL, Fan ST, Ng M . Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response. Am J Clin Pathol 2000; 113: 355\u201363.","journal-title":"Am J Clin Pathol"},{"key":"BFaps201234_CR21","first-page":"3352","volume":"5","author":"A Abolhoda","year":"1999","unstructured":"Abolhoda A, Wilson AE, Ross H, Danenberg PV, Burt M, Scotto KW . Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin. Clin Cancer Res 1999; 5: 3352\u20136.","journal-title":"Clin Cancer Res"},{"key":"BFaps201234_CR22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1517\/17425247.5.5.499","volume":"5","author":"G Wang","year":"2008","unstructured":"Wang G, Uludag H . Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles. Expert Opin Drug Deliv 2008; 5: 499\u2013515.","journal-title":"Expert Opin Drug Deliv"},{"key":"BFaps201234_CR23","first-page":"3867","volume":"29","author":"A Mukerjee","year":"2009","unstructured":"Mukerjee A, Vishwanatha JK . Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res 2009; 29: 3867\u201375.","journal-title":"Anticancer Res"},{"key":"BFaps201234_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.nurt.2009.01.018","volume":"6","author":"MF Bennewitz","year":"2009","unstructured":"Bennewitz MF, Saltzman WM . Nanotechnology for delivery of drugs to the brain for epilepsy. Neurotherapeutics 2009; 6: 323\u201336.","journal-title":"Neurotherapeutics"},{"key":"BFaps201234_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1477-3155-5-3","volume":"5","author":"S Bisht","year":"2007","unstructured":"Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A . Polymeric nanoparticle-encapsulated curcumin (\u201cnanocurcumin\u201d): a novel strategy for human cancer therapy. J Nanobiotechnology 2007; 5: 3.","journal-title":"J Nanobiotechnology"},{"key":"BFaps201234_CR26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.bcp.2009.09.003","volume":"79","author":"P Anand","year":"2010","unstructured":"Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR, et al. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol 2010; 79: 330\u20138.","journal-title":"Biochem Pharmacol"},{"key":"BFaps201234_CR27","doi-asserted-by":"publisher","first-page":"9280","DOI":"10.1021\/jf202135j","volume":"59","author":"X Xie","year":"2011","unstructured":"Xie X, Tao Q, Zou Y, Zhang F, Guo M, Wang Y, et al. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. J Agric Food Chem 2011; 59: 9280\u20139.","journal-title":"J Agric Food Chem"},{"key":"BFaps201234_CR28","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1002\/app.23082","volume":"100","author":"M Guerrouache","year":"2006","unstructured":"Guerrouache M, Karakasyan C, Gaillet C, Canva M, Millot MC . Immobilization of a functionalized poly(ethylene glycol) onto beta-cyclodextrin-coated surfaces by formation of inclusion complexes: Application to the coupling of proteins. J Appl Polym Sci 2006; 100: 2362\u201370.","journal-title":"J Appl Polym Sci"},{"key":"BFaps201234_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejps.2009.02.008","volume":"37","author":"C Chittasupho","year":"2009","unstructured":"Chittasupho C, Xie SX, Baoum A, Yakovleva T, Siahaan TJ, Berkland CJ . ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. Eur J Pharm Sci 2009; 37: 141\u201350.","journal-title":"Eur J Pharm Sci"},{"key":"BFaps201234_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ejps.2009.02.019","volume":"37","author":"J Shaikh","year":"2009","unstructured":"Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MN . Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 2009; 37: 223\u201330.","journal-title":"Eur J Pharm Sci"},{"key":"BFaps201234_CR31","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1039\/B602830F","volume":"5","author":"ME Wieder","year":"2006","unstructured":"Wieder ME, Hone DC, Cook MJ, Handsley MM, Gavrilovic J, Russell DA . Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a 'Trojan horse'. Photochem Photobiol Sci 2006; 5: 727\u201334.","journal-title":"Photochem Photobiol Sci"},{"key":"BFaps201234_CR32","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s12272-011-1012-4","volume":"34","author":"P Iangcharoen","year":"2011","unstructured":"Iangcharoen P, Punfa W, Yodkeeree S, Kasinrerk W, Ampasavate C, Anuchapreeda S, et al. Anti-P-glycoprotein conjugated nanoparticles for targeting drug delivery in cancer treatment. Arch Pharm Res 2011; 34: 1679\u201389.","journal-title":"Arch Pharm Res"},{"key":"BFaps201234_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1747-1028-3-14","volume":"3","author":"G Sa","year":"2008","unstructured":"Sa G, Das T . Anti cancer effects of curcumin: cycle of life and death. Cell Div 2008; 3: 14.","journal-title":"Cell Div"},{"key":"BFaps201234_CR34","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB . Bioavailability of curcumin: problems and promises. Mol Pharm 2007; 4: 807\u201318.","journal-title":"Mol Pharm"},{"key":"BFaps201234_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","volume":"86","author":"R Singh","year":"2009","unstructured":"Singh R . Lillard JW Jr . Nanoparticle-based targeted drug delivery. Exp Mol Pathol 2009; 86: 215\u201323.","journal-title":"Exp Mol Pathol"},{"key":"BFaps201234_CR36","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1039\/c0nr00758g","volume":"3","author":"M Gou","year":"2011","unstructured":"Gou M, Men K, Shi H, Xiang M, Zhang J, Song J, et al. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale 2011; 3: 1558\u201367.","journal-title":"Nanoscale"},{"key":"BFaps201234_CR37","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1592\/phco.21.9.778.34558","volume":"21","author":"CJ Matheny","year":"2001","unstructured":"Matheny CJ, Lamb MW, Brouwer KR, Pollack GM . Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation. Pharmacotherapy 2001; 21: 778\u201396.","journal-title":"Pharmacotherapy"},{"key":"BFaps201234_CR38","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ijpharm.2006.12.002","volume":"331","author":"A Cirstoiu-Hapca","year":"2007","unstructured":"Cirstoiu-Hapca A, Bossy-Nobs L, Buchegger F, Gurny R, Delie F . Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles. Int J Pharm 2007; 331: 190\u20136.","journal-title":"Int J Pharm"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps201234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201234","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:28:13Z","timestamp":1684412893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps201234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,14]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["BFaps201234"],"URL":"https:\/\/doi.org\/10.1038\/aps.2012.34","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,14]]}}}